David B. Darr

4.8k total citations
49 papers, 2.7k citations indexed

About

David B. Darr is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David B. Darr has authored 49 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 23 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David B. Darr's work include Cancer Cells and Metastasis (6 papers), Nanoparticle-Based Drug Delivery (6 papers) and Cancer-related Molecular Pathways (6 papers). David B. Darr is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Nanoparticle-Based Drug Delivery (6 papers) and Cancer-related Molecular Pathways (6 papers). David B. Darr collaborates with scholars based in United States, Germany and United Kingdom. David B. Darr's co-authors include Charles M. Perou, Norman E. Sharpless, Jerry Usary, William C. Zamboni, Kelly S. Clark, Christin E. Burd, Stephanie A. Montgomery, Janakiraman Krishnamurthy, Allison M. Deal and Diego H. Castrillón and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

David B. Darr

44 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David B. Darr United States	25	1.4k	937	470	426	375	49	2.7k
Carlo Leonetti Italy	41	3.2k 2.3×	1.8k 1.9×	360 0.8×	684 1.6×	353 0.9×	129	5.1k
Jiang Yang United States	19	1.3k 1.0×	708 0.8×	336 0.7×	678 1.6×	244 0.7×	45	2.7k
Rodney B. Luwor Australia	32	2.0k 1.4×	1.5k 1.6×	485 1.0×	867 2.0×	428 1.1×	95	3.7k
Julie A. Ellerhorst United States	35	1.3k 0.9×	1.5k 1.6×	794 1.7×	357 0.8×	643 1.7×	71	3.2k
Arati Sharma United States	30	2.5k 1.7×	1.1k 1.1×	721 1.5×	399 0.9×	156 0.4×	90	3.9k
Junnian Zheng China	30	1.7k 1.2×	1.1k 1.2×	492 1.0×	561 1.3×	310 0.8×	146	3.0k
Roberto Ronca Italy	35	3.0k 2.1×	882 0.9×	1.4k 2.9×	805 1.9×	432 1.2×	116	5.0k
Alan Serrels United Kingdom	28	1.5k 1.1×	740 0.8×	473 1.0×	366 0.9×	192 0.5×	40	3.3k
Shamit K. Dutta United States	31	1.6k 1.1×	723 0.8×	256 0.5×	565 1.3×	180 0.5×	62	2.6k
Joshua A. McCarroll Australia	30	2.1k 1.5×	1.3k 1.3×	382 0.8×	581 1.4×	206 0.5×	61	4.0k

Countries citing papers authored by David B. Darr

Since Specialization

Citations

This map shows the geographic impact of David B. Darr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Darr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Darr more than expected).

Fields of papers citing papers by David B. Darr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Darr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Darr. The network helps show where David B. Darr may publish in the future.

Co-authorship network of co-authors of David B. Darr

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Darr. A scholar is included among the top collaborators of David B. Darr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Darr. David B. Darr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tarpley, Michael, Jose Roques, Christopher P. Laudeman, et al.. (2021). Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies. European Journal of Pharmaceutical Sciences. 162. 105821–105821. 29 indexed citations

Bhatt, Aadra P., Samuel J. Pellock, Kristen A. Biernat, et al.. (2020). Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy. Proceedings of the National Academy of Sciences. 117(13). 7374–7381. 150 indexed citations

Cheng, Ning, Robert D. Junkins, Clément N. David, et al.. (2018). A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer. JCI Insight. 3(22). 211 indexed citations

Tanioka, Maki, Kevin R. Mott, Daniel P. Hollern, et al.. (2018). Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer. Genome Medicine. 10(1). 86–86. 14 indexed citations

Brighton, Hailey E., Steven P. Angus, Tao Bo, et al.. (2017). New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging. Cancer Research. 78(2). 542–557. 57 indexed citations

Hughes, Philip F., David A. Alcorta, Takuya Osada, et al.. (2017). A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in Vivo. ACS Chemical Biology. 12(4). 1047–1055. 41 indexed citations

Cozzo, Alyssa J., Sneha Sundaram, Yuanyuan Qin, et al.. (2016). cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer. SpringerPlus. 5(1). 348–348. 16 indexed citations

He, Zhijian, Xiaomeng Wan, Anita Schulz, et al.. (2016). A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity. Biomaterials. 101. 296–309. 159 indexed citations

Karginova, Olga, Marni B. Siegel, Amanda E.D. Van Swearingen, et al.. (2015). Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA -Mutated and BRCA –Wild-Type Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 14(4). 920–930. 53 indexed citations

10.

Chandler, Ronald L., Jeffrey S. Damrauer, Jesse R. Raab, et al.. (2015). Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. Nature Communications. 6(1). 6118–6118. 230 indexed citations

11.

Burd, Christin E., Wenjin Liu, Kelly S. Clark, et al.. (2014). Mutation-Specific RAS Oncogenicity Explains NRAS Codon 61 Selection in Melanoma. Cancer Discovery. 4(12). 1418–1429. 135 indexed citations

12.

Song, Gina, David B. Darr, Charlene Santos, et al.. (2014). Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models. Clinical Cancer Research. 20(23). 6083–6095. 85 indexed citations

13.

Sundaram, Sneha, Alex J. Freemerman, Joseph A. Galanko, et al.. (2014). Obesity-Mediated Regulation of HGF/c-Met Is Associated with Reduced Basal-Like Breast Cancer Latency in Parous Mice. PLoS ONE. 9(10). e111394–e111394. 15 indexed citations

14.

Sundaram, Sneha, Alex J. Freemerman, Megan Huang, et al.. (2014). Weight Loss Reversed Obesity-Induced HGF/c-Met Pathway and Basal-Like Breast Cancer Progression. Frontiers in Oncology. 4. 175–175. 29 indexed citations

15.

Usary, Jerry, Wei Zhao, David B. Darr, et al.. (2013). Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice. Clinical Cancer Research. 19(17). 4889–4899. 40 indexed citations

16.

Burd, Christin E., Jessica A. Sorrentino, Kelly S. Clark, et al.. (2013). Monitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model. Cell. 152(1-2). 340–351. 305 indexed citations

17.

Roberts, Patrick J., Jerry Usary, David B. Darr, et al.. (2012). Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models. Clinical Cancer Research. 18(19). 5290–5303. 107 indexed citations

18.

Roberts, Patrick J., John Bisi, Jay C. Strum, et al.. (2012). Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy. JNCI Journal of the National Cancer Institute. 104(6). 476–487. 215 indexed citations

19.

Siamakpour‐Reihani, Sharareh, Joseph M. Caster, Andrew Courtwright, et al.. (2011). The Role of Calcineurin/NFAT in SFRP2 Induced Angiogenesis—A Rationale for Breast Cancer Treatment with the Calcineurin Inhibitor Tacrolimus. PLoS ONE. 6(6). e20412–e20412. 74 indexed citations

20.

Darr, David B., et al.. (1996). North American timber trends study. United Nations eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact